Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Am J Transplant. 2018 Nov 10;19(4):1168–1177. doi: 10.1111/ajt.15143

Fig. 1:

Fig. 1:

Clinical evolution of FVCAs for up to an 8-year interval showing changes associated with chronic rejection (A). Whitey patches on allograft with permanent telangiectasias in one of the FVCA recipients, suggestive of chronic changes (B).